The novel antipsychotic aripiprazole is a partial agonist at short and long isoforms of D2 receptors linked to the regulation of adenylyl cyclase activity and prolactin release-Reference-Cited by-同舟云学术

The novel antipsychotic aripiprazole is a partial agonist at short and long isoforms of D2 receptors linked to the regulation of adenylyl cyclase activity and prolactin release

Published:2004-04 Issue:1-2 Volume:1003 Page:9-17
ISSN:0006-8993
Container-title:Brain Research
language:en
Short-container-title:Brain Research

Author:

Aihara Koutoku,Shimada Jun,Miwa Takashi,Tottori Katsura,Burris Kevin D.,Yocca Frank D.,Horie Masato,Kikuchi Tetsuro

Publisher

Elsevier BV

Subject

Developmental Biology,Clinical Neurology,Molecular Biology,General Neuroscience

Reference35 articles.

1. Coupling of a cloned rat dopamine-D2 receptor to inhibition of adenylyl cyclase and prolactin secretion;Albert;J. Biol. Chem.,1990

2. Specific induction of a functional endogenous D2 short dopamine receptor in GH4C1 cells;Allard;Biochem. Biophys. Res. Commun.,1993

3. Direct action of serotonin on prolactin, growth hormone, corticotropin and luteinizing hormone release in cocultures of anterior and posterior pituitary lobes: autocrine and/or paracrine action of vasoactive intestinal peptide;Balsa;Neuroendocrinology,1998

4. Dopamine: a prolactin-inhibiting hormone;Ben-Jonathan;Endocr. Rev.,1985

5. Comparison of the forms of the dopamine D2 receptor expressed in GH4C1 cells;Burris;Proc. Soc. Exp. Biol. Med.,1994

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of CYP2D6 and CYP3A4 polymorphisms on aripiprazole and dehydroaripiprazole concentrations in patients undergoing long-acting treatment;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2024-12

2. Chronic Aripiprazole and Trazodone Polypharmacy Effects on Systemic and Brain Cholesterol Biosynthesis;Biomolecules;2023-08-28

3. The Dopamine D2 Receptor Partial Agonist Antipsychotics, Aripiprazole, and Brexpiprazole;NeuroPsychopharmacotherapy;2022

4. Discovery research and development history of the dopamine D 2 receptor partial agonists, aripiprazole and brexpiprazole;Neuropsychopharmacology Reports;2021-05-07

5. The Dopamine D2 Receptor Partial Agonist Antipsychotics, Aripiprazole, and Brexpiprazole;NeuroPsychopharmacotherapy;2021